ARS Gets Early FDA Approval For Needle-Free Epinephrine
ARS Will Take On Injectable Epinephrine Products With FDA-Approved Neffy
ARS will compete directly with EpiPen and other injectable products with inhaled neffy as the first needle-free epinephrine therapy for severe allergy attacks. EU approval is thought imminent.
